Recombinant allergens: From production and characterization to diagnosis, treatment, and prevention of allergy

Methods

Volumn 32, Issue 3, 2004, Pages 207-208

  Valenta, Rudolf ^a   Kraft, Dietrich ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; DNA VACCINE; EPITOPE; IMMUNOGLOBULIN E ANTIBODY; RECOMBINANT PROTEIN;

ALLERGY; ANALYTIC METHOD; ASTHMA; ATOPIC DERMATITIS; CONJUNCTIVITIS; DNA MICROARRAY; EDITORIAL; GENE TECHNOLOGY; GENETIC ENGINEERING; HUMAN; IMMEDIATE TYPE HYPERSENSITIVITY; IMMUNOPATHOLOGY; IMMUNOREACTIVITY; IMMUNOTHERAPY; PRIORITY JOURNAL; SENSITIZATION; STRUCTURE ANALYSIS; SYMPTOMATOLOGY; TECHNOLOGY;

EID: 1042299004     PISSN: 10462023     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ymeth.2003.08.001     Document Type: Editorial

References (14)

1. Kay A.B. Allergy and allergic diseases. 1997;Blackwell Science, Oxford.
2. Ishizaka K., Ishizaka T., Hornbrook M.M. Physicochemical properties of human reaginic antibody. J. Immunol. 97:1966;840-845.
3. Johansson S.G.O., Bennich H. Immunological studies of an atypical (myeloma) immunoglobulin. Immunology. 13:1967;381-394.
4. Blackley C.H. Hay Fever; Its Causes, Treatment, and Effective Prevention. 1880;Balliere, London.
5. Noon L. Prophylactic inoculation against hay fever. Lancet. 1:1911;1572.
6. J. Bousquet, R. Lockey, H.J. Malling, and The WHO Panel Members, Allergen immunotherapy: therapeutic vaccines for allergic diseases. Allergy 53 (1999) 1-42.
7. R. Valenta, T. Ball, M. Focke, B. Linhart, N. Mothes, V. Niederberger, S. Spitzauer, I. Swoboda, S. Vrtala, K. Westritschnig, D. Kraft, Immunotherapy of allergic disease, Adv. Immunol. (2003), in press.
8. Valenta R., Lidholm J., Niederberger V., Hayek B., Kraft D., Grönlund H. The recombinant allergen-based concept of component-resolved diagnostics and immunotherapy (CRD and CRIT). Clin. Exp. Allergy. 29:1999;896-904.
9. Valenta R., Kraft D. From allergen structure to new forms of allergen-specific immunotherapy. Curr. Opin. Immunol. 14:2002;718-727.
10. Valenta R., Kraft D. Recombinant allergen molecules: tools to study effector cell activation. Immunol. Rev. 179:2001;119-127.
11. Valenta R., Duchene M., Vrtala S., Birkner T., Ebner C., Hirschwehr R., Breitenbach M., Rumpold H., Scheiner O., Kraft D. Recombinant allergens for immunoblot diagnosis of tree-pollen allergy. J. Allergy Clin. Immunol. 88:1991;889-894.
12. Valenta R., Vrtala S., Ebner C., Kraft D., Scheiner O. Diagnosis of grass pollen allergy with recombinant timothy grass (Phleum pratense ) pollen allergens. Int. Arch. Allergy Immunol. 97:1992;287-294.
13. Hiller R., Laffer S., Harwanegg C., Huber M., Schmidt W.M., Twardosz A., Barletta B., Becker W.M., Blaser K., Breiteneder H., Chapman M., Crameri R., Duchene M., Ferreira F., Fiebig H., Hoffmann-Sommergruber K., King T.P., Kleber-Janke T., Kurup V.P., Lehrer S.B., Lidholm J., Müller U., Pini C., Reese G., Scheiner O., Scheynius A., Shen H.D., Spitzauer S., Suck R., Swoboda I., Thomas W., Tinghino R., van Hage-Hamsten M., Virtanen T., Kraft D., Müller M., Valenta R. Microarrayed allergen molecules: diagnostic gatekeepers for allergy treatment. FASEB J. 16:2002;414-416.
14. Valenta R. The future of antigen-specific immunotherapy of allergy. Nat. Rev. Immunol. 2:2002;446-453.